Pluri Inc. (PLUR): Nasdaq/NYSE listing notice — Pluri receives Nasdaq delisting notice for failure to meet $35M market value of listed securities

Pluri Inc.

Nasdaq notified Pluri on Jan. 20, 2026 that its market value of listed securities fell below the required $35M minimum.
Company also fails alternative listing standards: stockholders' equity < $2.5M or net income from continuing operations < $500K.
Pluri has 180 days (until July 20, 2026) to regain compliance; shares continue trading under PLUR on Nasdaq Capital Market.
If compliance not regained, Nasdaq may delist; Pluri can appeal to a Hearings Panel and potentially stay delisting.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Pluri Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

January 20, 2026, Pluri Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum of $35 million in market value of listed securities (“MVLS”) for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”), nor is it in compliance with either of the alternative listing standards, including having stockholders’ equity of at least $2.5 million or net income of $5

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Pluri Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-006685

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.